Archive February 2008
GENITO-URINARY CANCER

What we know
What information do we have about the Eastern Board area?
What is the result of this on our health locally?
Policies
What is happening in the Eastern Board area?

 

Statistics
Click here for statistics

 
Links
Click here for Links
 
Documents
Click here for Documents
What we know

Cancer is a term for a group of diseases in which abnormal cells start to develop in a part of the body. These abnormal malignant cells continue to grow and then spread (metastasize) through the blood stream and lymphatic system to other parts of the body such as the liver, bone or brain. This section looks at the prostate gland in males and the cervix in females. Cancer of the cervix or neck of the womb can be detected by a cervical smear test. This is done as part of the national cervical screening programme. Cancer of the prostate gland in males becomes more common with increasing age. There are calls for prostate cancer screening, but the current test gives too many false positive results. This means that people may undergo unnecessary treatment. Research continues for a more specific test.


The Northern Ireland Cancer Registry (NICR), based in Queen's University Belfast, collects information about cancer in Northern Ireland from a range of sources to get the best possible estimate of the number and type of cases of cancer in Northern Ireland. The NICR then provides information about the number of new cases of cancer each year (incidence) and the number of existing cases of cancer (prevalence) for all the different cancer types. The NICR now has data going back to 1993, which enables us to see the trends in cancer types over time.

Cancer is predominantly a disease of middle age and old age. According to data from the Northern Ireland Cancer Registry, half of all patients are aged 68 or over at the time of diagnosis. Females have a 1-in-8 chance and males a 1-in-6 chance, of dying of cancer by age 74. One in three people will develop some type of cancer during their lifetime, but the news is not all bad. With increasing research and new treatment, many types of cancer can be cured or at least halted for a time.

The Northern Ireland Cancer Registry reports that in 2001, cancer of the prostate gland was the third most common cancer in males in Northern Ireland, representing approximately 12% of male cancers registered. Half of the cases occurred in men aged over 74 years and few cases occurred under the age of 50. Prostate cancer was the second most common cause of cancer death in males.

The Northern Ireland Cancer Registry reports that in 2001, cancer of the cervix was the twelfth most common cancer in females in Northern Ireland, representing approximately 2% of all female cancers registered. Half of the cases were diagnosed in women below 48 years. Cervical cancer was the twentieth most common cause of cancer death in females.

Back to top

What information do we have about the Eastern Board area?

In 2005, there were 1591 deaths from all causes of cancer: 810 males and 781 females. Of these, 87 men died from cancer of the prostate gland. When we look back to 1991, the rate of death for cancer of the prostate has been decreasing for men. The rates fluctuate from year to year, because of the small numbers of deaths, but the trend is downwards. This could be due to fewer cases occurring, fewer cases diagnosed, earlier diagnosis leading to better treatment, or a combination of causes.

Cancer of the cervix accounted for 10 deaths in females in the Eastern Board area. When we look back to 1991, the rate of death for cancer of the cervix has been decreasing for women. The rates fluctuate from year to year, because of the small numbers of deaths, but the trend is downwards. Once again, this could be due to fewer cases occurring, fewer cases diagnosed, earlier diagnosis leading to better treatment, or a combination of causes.

What is the result of this on our health locally?

Prostate cancer
There are a number of factors that increase the risk of prostate cancer. Unfortunately, most of these are factors that cannot be changed. For example:

The risk of prostate cancer increases with age;
Prostate cancer is more likely in those with a family history of the condition;
The incidence of prostate cancer is higher in African Americans (about twice that of white men), and lowest in Asian and Oriental men.


Research has found that a diet high in animal fats and proteins and low levels of selenium may increase the risk of developing prostate cancer.

What about prostate cancer screening?
Screening is not a diagnostic test. Finding an abnormal result in screening may show that a person is at risk of a disease but further tests will be needed to make an accurate diagnosis. The natural history of prostate cancer is not fully understood. Prostate cancer is not a single disease but more a spectrum of diseases ranging from very aggressive to slow growing tumours, which may not cause any symptoms or shorten life. Over 90% of prostate cancer deaths occur in the 65 and over age group. By the age of 80 about 60-70% of men will have some cancer cells in their prostate. However only around 1 in 30 of these men will actually die of their prostate cancer.

PSA (Prostate Specific Antigen) is a substance made by the prostate gland, which naturally leaks out into the blood stream. A raised PSA can be an early indication of prostate cancer. However, other conditions that are not cancer (e.g. enlargement of the prostate, prostatitis, urinary infection) can also cause a rise in PSA. Approximately 2 out of 3 men with a raised PSA level will not have prostate cancer and the PSA test can also miss prostate cancer.

The National Screening Committee reviews the latest research evidence to advise the government about whether a screening test should be introduced, continued, amended or discontinued. The National Screening Committee currently advises that PSA testing should not be introduced as a screening test as it produces too many false positive and false negative tests. Men may then undergo unnecessary and inappropriate treatment for a disease that they do not have. Research into a more accurate method of testing is a priority and ongoing.

Cancer of the cervix
Cancer of the cervix is linked to sexual behaviour. The risk of developing cancer of the cervix is increased in:

women who have had many sexual partners
women who are carrying certain types of Human Papilloma Virus (HPV)
women who smoke ( women who smoke are about twice as likely to develop cervical cancer as non-smokers)
those who have had their first baby at a young age
those who have had more than one pregnancy (the risk rises with the number of pregnancies)
women in manual social classes compared with the risk in women from non-manual social classes


Using a condom gives some protection against cervical cancer while long-term use of oral contraceptives increases the risk. However, the benefits of taking oral contraceptives far outweigh the risks for the majority of women.

Cancer of the cervix or neck of the womb is usually detected by a cervical smear test. The woman undergoes an examination and some cells are taken from the neck of the womb and viewed under a microscope to see if there are any abnormal cells. Certain types of abnormal cells are an early warning that cancer may develop. Women with these abnormal cells require further examination to diagnose and treat any developing cancer.

Cervical cancer screening

In Northern Ireland all women between the ages of 20 and 64 are invited to attend every five years for a smear test. The best way for a woman to reduce the risk of cancer of the cervix is to ensure that she attends for this test when invited. For further details of the screening programme please refer to the cervical screening section of this website.

 

Back to top

Policies

The Report of the Expert Advisory Group on Cancer, "A Policy Framework for Commissioning Cancer Services" (the Calman/Hine Report), 1995, recommended a framework for cancer services in England and Wales.

The Cancer Working Group of the Department of Health and Social Services (N.I.) built upon the Calman/Hine principles and in its 1996 report "Cancer Services: Investing for the Future" (the Campbell Report), described a structure for future cancer services in Northern Ireland.

The Eastern Health and Social Services Board Palliative Care Strategic Action Plan 2002 – 2007 was published in 2002 (Palliative Care Services - The Next 5 Years).

It is also important to review and consider recent guidance:

Regional Guidance:

Review of clinical genetic services in Northern Ireland
Gynaecological Cancer Guidelines
Dermatological Cancer Guidelines
Haematological Cancer Guidelines
Endocrine Cancer Guidelines
Lymphoedema Review
Review of Clinical Pathology Laboratory Services

National Institute of Clinical Excellence (NICE) National Collaborating Centre for Cancer Guidance:

Breast Cancer Service Guidance (August 2002)
Urological Cancers Service Guidance (September 2002)
Haemato-oncology cancer service guidance (October 2003)
Supportive and Palliative care (March 2004)
Head and Neck Cancers (Anticipated publication date October 2004)
Lung cancer (Anticipated publication date January 2005)
Colorectal cancer (Anticipated publication date January 2005)
Referral guidelines for suspected cancer (Anticipated publication date March 2005)
Prostate cancer ((Anticipated publication date to be confirmed)

NHS Modernisation Agency Cancer Services Collaborative Service Improvement Guides:

Multidisciplinary Team Resource Guide
Breast Service Improvement Guide
Chemotherapy Service Improvement Guide
Radiotherapy Service Improvement Guide
Upper GI Service Improvement Guide
Urology Service Improvement Guide
Patient and Carer Experience: A Service Improvement Guide

 

Back to top

What is happening in the Eastern Board area?
Northern Ireland Cancer Network
The Eastern Board is currently in the process of reviewing current cancer service provision in light of recent regional developments such as the Northern Ireland Cancer Network (NICaN) and the Regional Cancer Services Framework group. This process will also review progress against the EHSSB Cancer Commissioning Group report recommendations.
Cervical screening programme
All women between the ages of 20-64 years of age are invited, either by the central screening office or by their own General Practitioners, to have the cervical smear test carried out. Although the regional programme operates at five-year intervals, many individual practitioners offer to screen women every three years.

In 1997 the Eastern Health and Social Services Board (EHSSB) convened a multi-agency Cancer Commissioning Group, with the remit to oversee implementation of policy on the prevention and treatment of cancer for Eastern Board residents. Seven Cancer Commissioning sub-groups were established to inform this process:

breast cancer;
lung cancer;
gastrointestinal cancers, including colorectal;
gynaecological cancers;
urological cancers;
palliative care;
cancer prevention.

 

In March 1998, the Eastern Board established the EHSSB Cancer Implementation Group which was tasked to take forward the recommendations from the Cancer Commissioning Group report. Site-specific implementation subgroups were (re)convened to take forward this work in phases.
Published in August, the EHSSB Cancer Commissioning Group report described the recommendations for future cancer services for Eastern Board residents. The report covered all aspects of care from prevention through to cure and palliation and outlined the strategic and resource implications of the proposed service models.
The Eastern Board area contains the Cancer Centre and two Cancer Units at the Belfast City Hospital and the Ulster Hospital. However, given the varied initial clinical presentation of malignant disease, general specialties within all acute Eastern Board hospitals continue to have an important role in investigation and diagnosis, local treatment where appropriate, and referral onward as part of multidisciplinary treatment.
Regional Cancer Centre
Construction of the new Regional Cancer Centre building on the Belfast City Hospital site commenced in 2002. The work is progressing well and is on schedule, with the building expected to be opened for clinical service at the start of 2006.


Back to top

 

For further information on this topic please contact us at publichealth@ehssb.n-i.nhs.uk

Eastern Health and Social Services Board Champion House, 12-22 Linenhall Street, Belfast BT2 8BS Telephone: (028) 9032 1313 Fax: (028) 9055 3681 Text Phone:(028) 9032 4980 Website: www.ehssb.org E-mail: pr@ehssb.n-i.nhs.uk
Site designed by areema.co.uk